Boundless Bio Files 8-K on Security Holder Votes
Ticker: BOLD · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1782303
| Field | Detail |
|---|---|
| Company | Boundless Bio, INC. (BOLD) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, 8-k
TL;DR
Boundless Bio filed an 8-K for security holder votes - standard corporate governance.
AI Summary
Boundless Bio, Inc. filed an 8-K on June 23, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions, but it is a standard procedural filing.
Why It Matters
This filing indicates that Boundless Bio held or is holding a meeting where security holders are voting on corporate matters, which is a routine but important part of corporate governance.
Risk Assessment
Risk Level: low — This is a routine procedural filing related to corporate governance and does not appear to contain material non-public information that would immediately impact stock price.
Key Players & Entities
- Boundless Bio, Inc. (company) — Registrant
- June 23, 2025 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of Boundless Bio's security holders?
The provided filing excerpt does not specify the exact matters submitted for a vote, only that such matters were presented.
When did the event related to the security holder vote occur or when was it reported?
The earliest event reported in this 8-K filing is dated June 23, 2025.
What is the principal executive office address for Boundless Bio, Inc.?
The principal executive offices are located at 10955 Alexandria Way, Suite 100, San Diego, California 92121.
What is Boundless Bio, Inc.'s telephone number?
The registrant's telephone number, including area code, is (858) 766-9912.
What is the SIC code for Boundless Bio, Inc.?
The Standard Industrial Classification code for Boundless Bio, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Boundless Bio, Inc. (BOLD).